David Mark Steinhaus

Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA.

Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA.

Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA.